Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Industrial Logistics Properties Trust | ILPT | Nov 25, 2024 | 3.81 | +2.97 |
Industrial Select Sector SPDR | XLI | Nov 25, 2024 | 143.54 | +0.62 |
Industrials ETF Vanguard | VIS | Nov 25, 2024 | 279.20 | +0.89 |
Infinera | INFN | Nov 25, 2024 | 6.62 | -0.30 |
InflaRx N.V | IFRX | Nov 25, 2024 | 2.12 | +1.92 |
Inflection Point Acquisition II | IPXX | Nov 25, 2024 | 10.68 | -0.19 |
Inflection Point Acquisition II Unit | IPXXU | Nov 25, 2024 | 10.86 | 0.00 |
Infobird | IFBD | Nov 25, 2024 | 1.92 | +4.35 |
Informatica | INFA | Nov 25, 2024 | 26.37 | +0.04 |
Information Services Group | III | Nov 25, 2024 | 3.57 | +1.13 |
Information Technology ETF Vanguard | VGT | Nov 25, 2024 | 621.29 | -0.05 |
Infosys ADR | INFY | Nov 25, 2024 | 22.84 | +0.22 |
InfuSystems | INFU | Nov 25, 2024 | 9.25 | -0.86 |
ING Group ADR | ING | Nov 25, 2024 | 15.34 | +0.39 |
Ingersoll Rand | IR | Nov 25, 2024 | 105.35 | +1.30 |
Ingevity | NGVT | Nov 25, 2024 | 50.21 | +3.40 |
Ingles Markets A | IMKTA | Nov 25, 2024 | 75.30 | +4.32 |
Ingram Micro Holding Corp | INGM | Nov 25, 2024 | 22.16 | 0.00 |
Ingredion | INGR | Nov 25, 2024 | 148.28 | +1.24 |
Inhibikase Therapeutics | IKT | Nov 25, 2024 | 2.34 | +1.30 |
Inhibrx Biosciences | INBX | Nov 25, 2024 | 14.86 | +5.54 |
InMed Pharmaceuticals | INM | Nov 25, 2024 | 4.50 | -3.43 |
InMode | INMD | Nov 25, 2024 | 19.52 | +2.63 |
INmune Bio | INMB | Nov 25, 2024 | 4.80 | -1.44 |
Innate Pharma ADR | IPHA | Nov 25, 2024 | 1.45 | -11.04 |
Inno Holdings | INHD | Nov 25, 2024 | 4.69 | -5.44 |
Innodata | INOD | Nov 25, 2024 | 45.39 | +1.38 |
Innospec | IOSP | Nov 25, 2024 | 119.95 | +0.17 |
InnovAge | INNV | Nov 25, 2024 | 4.75 | -2.86 |
Innovate | VATE | Nov 25, 2024 | 5.92 | -1.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.